切换至 "中华医学电子期刊资源库"

中华肝脏外科手术学电子杂志 ›› 2022, Vol. 11 ›› Issue (03) : 273 -277. doi: 10.3877/cma.j.issn.2095-3232.2022.03.012

临床研究

器官保存液病原体与肝移植受者感染关系分析
刘剑戎1, 谢芝芝2, 黎利娟1, 吕海金1, 安玉玲1, 易小猛1, 魏绪霞1, 席云2, 易慧敏1, 熊天威3,()   
  1. 1. 510630 广州,中山大学附属第三医院外科ICU
    2. 510630 广州,中山大学附属第三医院检验科
    3. 510630 广州,中山大学附属第三医院器官捐献管理办公室
  • 收稿日期:2022-02-10 出版日期:2022-06-10
  • 通信作者: 熊天威
  • 基金资助:
    广东省自然科学基金(2021A1515012382)

Relationship between pathogens in organ preservation solution and infection of liver transplant recipients

Jianrong Liu1, Zhizhi Xie2, Lijuan Li1, Haijin Lyu1, Yuling An1, Xiaomeng Yi1, Xuxia Wei1, Yun Xi2, Huimin Yi1, Tianwei Xiong3,()   

  1. 1. Surgical ICU, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
    2. Department of Clinical Laboratory, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
    3. Organ Donation Management Office, the Third Affiliated Hospital of Sun Yat-sen University, Guangzhou 510630, China
  • Received:2022-02-10 Published:2022-06-10
  • Corresponding author: Tianwei Xiong
引用本文:

刘剑戎, 谢芝芝, 黎利娟, 吕海金, 安玉玲, 易小猛, 魏绪霞, 席云, 易慧敏, 熊天威. 器官保存液病原体与肝移植受者感染关系分析[J]. 中华肝脏外科手术学电子杂志, 2022, 11(03): 273-277.

Jianrong Liu, Zhizhi Xie, Lijuan Li, Haijin Lyu, Yuling An, Xiaomeng Yi, Xuxia Wei, Yun Xi, Huimin Yi, Tianwei Xiong. Relationship between pathogens in organ preservation solution and infection of liver transplant recipients[J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2022, 11(03): 273-277.

目的

探讨器官保存液病原微生物培养情况及其对肝移植受者术后感染的影响。

方法

回顾性分析2017年10月至2018年12月在中山大学附属第三医院行肝移植的273例受者临床资料。受者和(或)家属签署知情同意书,符合医学伦理学规定。其中男238例,女35例;年龄16~77岁,中位年龄49岁。对器官保存液和受者移植术后血、尿、痰、腹腔积液等标本行细菌、真菌检测及药物敏感分析,分析器官来源的病原体传播和导致移植受体感染的情况。

结果

器官保存液病原体培养阳性率45.8%(125/273),常见细菌依次为表皮葡萄球菌20例,人葡萄球菌12例,屎肠球菌11例,鲍曼不动杆菌11例,肺炎克雷伯菌10例。其中鲍曼不动杆菌和肺炎克雷伯菌均对不同抗生素具有耐药性,鲍曼不动杆菌对碳青霉烯类抗生素耐药率高达91%,而肺炎克雷伯杆菌对碳青霉烯类抗生素耐药率也高达30%。肝移植术后出现可能器官来源的病原体传播9例,其中鲍曼不动杆菌5例,屎肠球2例,表皮葡萄球菌2例,肺炎克雷伯菌1例。出现可能器官来源的病原体感染2例,分别为泛耐药的鲍曼不动杆菌和肺炎克雷伯菌。器官来源的病原微生物培养常见阳性部位为腹腔,其次为肺部、血液、腹部伤口。

结论

器官保存液中微生物复杂多样,多数来源于皮肤或肠道定植菌群。多重耐药菌易导致受体感染并产生不良后果。腹腔是器官来源病原体检出率最高的部位。

Objective

To investigate the microbial cultivation of pathogens in organ preservation solution and its impact on the postoperative infection of liver transplant recipients.

Methods

Clinical data of 273 recipients undergoing liver transplantation in the Third Affiliated Hospital of Sun Yat-sen University from October 2017 to December 2018 were retrospectively analyzed. The informed consents of all recipients and (or) families were obtained and the local ethical committee approval was received. Among them, 238 patients were male and 35 female, aged from 16 to 77 years, with a median age of 49 years. Bacterial, fungal detection and drug sensitivity analysis were performed for the organ preservation solution and blood, urine, sputum, ascites of recipients after liver transplantation. The transmission of organ-derived pathogens and the infection of transplant recipients were analyzed.

Results

The positive rate of pathogen culture in organ preservation solution was 45.8%(125/273). The common bacteria mainly consisted of Staphylococcus epidermidis (n=20), Staphylococcus aureus (n=12), Enterococcus faecalis (n=11), Acinetobacter baumannii (n=11) and Klebsiella pneumoniae (n=10). Acinetobacter baumannii and Klebsiella pneumoniae were resistant to different antibiotics. The resistance rate of Acinetobacter baumannii to carbapenems was 91%, and 30% for Klebsiella pneumoniae to carbapenems. After liver transplantation, potential organ-derived pathogen transmission was observed in 9 recipients, including 5 cases of Acinetobacter baumannii, 2 cases of Enterococcus faecalis, 2 cases of Staphylococcus epidermidis and 1 case of Klebsiella pneumoniae. 2 recipients presented with potential organ-derived pathogen infection, which were pan-drug resistant Acinetobacter baumannii and Klebsiella pneumoniae. The common sites of positive organ-derived pathogens were abdominal cavity, followed by lung, blood and abdominal wounds.

Conclusions

The pathogens in organ preservation solution are complex and diverse, most of which are derived from skin or intestinal flora. Multi-drug-resistant bacteria are likely to lead to infection of recipients and adverse events. Abdominal cavity is the part with highest detection rate of organ-derived pathogens.

表1 器官保存液病原微生物培养结果
表2 器官保存液中鲍曼不动杆菌和肺炎克雷伯菌的耐药率
表3 肝移植受者器官来源病原微生物培养阳性部位
[1]
中华医学会器官移植学分会. 器官移植供者来源性感染诊疗技术规范(2019版)[J]. 器官移植, 2019, 10(4):369-375.
[2]
张建蕊,孙丽莹,朱志军,等.供者来源性感染对肝移植受者的影响[J/CD]. 实用器官移植电子杂志, 2018, 6(1):17-20.
[3]
Iida T, Kaido T, Yagi S, et al. Posttransplant bacteremia in adult living donor liver transplant recipients[J]. Liver Transpl, 2010, 16(12):1379-1385.
[4]
Zhang L, Zeng L, Gao X, et al. Transformation of organ donation in China[J]. Transpl Int, 2015, 28(4):410-415.
[5]
Zibari GB, Lipka J, Zizzi H, et al. The use of contaminated donor organs in transplantation[J]. Clin Transplant, 2000,14(4 Pt 2):397-400.
[6]
Kim YJ, Jun YH, Choi HJ, et al. Impact of enterococcal bacteremia in liver transplant recipients[J]. Transplant Proc, 2019, 51(8):2766-2770.
[7]
Kim YJ, Kim SI, Lee YD, et al. Carbapenem-resistant acinetobacter baumannii bacteremia in liver transplant recipients[J]. Transplant Proc, 2018, 50(4):1132-1135.
[8]
王兴强, 刘懿禾, 蔡金贞, 等. 实体器官移植受者耐碳青霉烯类肠杆菌科细菌定植情况观察[J]. 山东医药, 2020, 60(21):40-43.
[9]
方翊天. 肝移植术后多重耐药菌感染的单中心临床研究[D].合肥: 安徽医科大学, 2021.
[10]
宋伟, 孙丽莹, 朱志军, 等. 供者来源性感染对肝移植受者预后的影响[J]. 器官移植, 2019, 10(6):708-712.
[11]
张飞, 廖贵益. 供者来源性感染对肾移植受者预后的影响[J].器官移植, 2021, 12(6):700-706.
[12]
Escolà-Vergé L, Los-Arcos I, José González-López J, et al. Successful liver transplantation despite donor-transmitted ESBL-producing Klebsiella pneumoniae infection: case report and review of the literature[J]. Transpl Infect Dis, 2017, 19(5):e12743.
[13]
Feijó MS, Galdino-Vasconcelos MR, Simões V, et al. Impact of donor positive blood culture in deceased donor liver transplantation[J]. Transplant Proc, 2020, 52(5):1236-1242.
[14]
李瑞东, 应悦, 裴家好, 等. 公民逝世后器官捐献供肝微生物学培养阳性对肝移植术后恢复及预后的影响[J/CD]. 实用器官移植电子杂志, 2020, 8(4):282-285.
[15]
席树强, 王洋, 曾强, 等. 肝移植术后供体来源耐碳青霉烯类肺炎克雷伯菌感染治疗分析[J/CD]. 实用器官移植电子杂志, 2020, 8(6):472-476.
[16]
陈志强, 张艳君, 薛晨, 等. 器官移植供者来源感染防控效果研究[J]. 中华医院感染学杂志, 2020, 30(4):631-636.
[17]
Yansouni CP, Dendukuri N, Liu G, et al. Positive cultures of organ preservation fluid predict postoperative infections in solid organ transplantation recipients[J]. Infect Control Hosp Epidemiol, 2012, 33(7): 672-680.
[18]
Oriol I, Sabe N, Càmara J, et al. The impact of culturing the organ preservation fluid on solid organ transplantation: a prospective multicenter cohort study[J]. Open Forum Infect Dis, 2019, 6(6): ofz180.
[19]
Corbel A, Ladrière M, Le Berre N, et al. Microbiological epidemiology of preservation fluids in transplanted kidney: a nationwide retrospective observational study[J]. Clin Microbiol Infect, 2020, 26(4):475-484.
[20]
Green MCovington STaranto S,et al. Donor-derived transmission events in 2013: a report of the Organ Procurement Transplant Network Ad Hoc Disease Transmission Advisory Committee[J]. Transplantation, 2015, 99(2):282-287.
[21]
黄露萍, 刘俊慧. 499株鲍曼不动杆菌临床分布及耐药性分析[J]. 实用检验医师杂志, 2016, 8(2): 97-99.
[22]
Ison MG, Nalesnik MA. An update on donor-derived disease transmission in organ transplantation[J]. Am J Transplant, 2011, 11(6):1123-1130.
[23]
Ye QFZhou WWan QQ. Donor-derived infections among Chinese donation after cardiac death liver recipients[J]. World J Gastroenterol, 2017, 23(31):5809-5816.
[24]
Yu X, Wang R, Peng W, et al. Incidence, distribution and clinical relevance of microbial contamination of preservation solution in deceased kidney transplant recipients: a retrospective cohort study from China[J]. Clin Microbiol Infect, 2019, 25(5):595-600.
[1] 李坤河, 寇萌佳, 邝立挺. 肝移植术后二次气管插管的危险因素及预测模型的建立[J]. 中华普通外科学文献(电子版), 2023, 17(05): 366-371.
[2] 中华医学会器官移植学分会, 中国医师协会器官移植医师分会, 上海医药行业协会. 中国肝、肾移植受者霉酚酸类药物应用专家共识(2023版)[J]. 中华移植杂志(电子版), 2023, 17(05): 257-272.
[3] 陆闻青, 陈昕怡, 任雪飞. 遗传代谢病儿童肝移植受者术后生活质量调查研究[J]. 中华移植杂志(电子版), 2023, 17(05): 287-292.
[4] 范铁艳, 李君, 陈虹. 肝移植术后新发戊型病毒性肝炎的诊治经验[J]. 中华移植杂志(电子版), 2023, 17(05): 293-296.
[5] 陈朔, 陈峰, 程飞, 项捷. 糖原累积病Ⅰ型并发胰腺炎肝移植术后胰腺梗死一例[J]. 中华移植杂志(电子版), 2023, 17(05): 300-302.
[6] 汤鹏昊, 张武. 肠道微生态与肝移植围手术期并发症相关研究进展[J]. 中华移植杂志(电子版), 2023, 17(05): 303-307.
[7] 叶啟发, 兰佳男. 中国人体器官捐献与异种移植[J]. 中华移植杂志(电子版), 2023, 17(04): 221-226.
[8] 祝丽娜, 杨子祯, 张迪, 张勇, 蔡金贞, 王建红. 超声造影在肝移植术后肝动脉并发症中的应用价值[J]. 中华移植杂志(电子版), 2023, 17(04): 240-245.
[9] 中国器官移植发展基金会器官移植受者健康管理专家委员会, 中国医师协会器官移植医师分会, 中华医学会器官移植学分会, 国家肝脏移植质控中心. 肝移植受者雷帕霉素靶蛋白抑制剂临床应用中国专家共识(2023版)[J]. 中华移植杂志(电子版), 2023, 17(04): 193-204.
[10] 严庆, 刘颖, 邓斐文, 陈焕伟. 微血管侵犯对肝癌肝移植患者生存预后的影响[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 624-629.
[11] 廖梅, 张红君, 金洁玚, 吕艳, 任杰. 床旁超声造影对肝移植术后早期肝动脉血栓的诊断价值[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 630-634.
[12] 李秉林, 吕少诚, 潘飞, 姜涛, 樊华, 寇建涛, 贺强, 郎韧. 供肝灌注液病原菌与肝移植术后早期感染的相关性分析[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 656-660.
[13] 吕垒, 冯啸, 何凯明, 曾凯宁, 杨卿, 吕海金, 易慧敏, 易述红, 杨扬, 傅斌生. 改良金氏评分在儿童肝豆状核变性急性肝衰竭肝移植手术时机评估中价值并文献复习[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 661-668.
[14] 王孟龙. 肿瘤生物学特征在肝癌肝移植治疗中的意义[J]. 中华肝脏外科手术学电子杂志, 2023, 12(05): 490-494.
[15] 王晓东, 汪恺, 葛昭, 丁忠祥, 徐骁. 计算机视觉技术在肝癌肝移植疗效提升中的研究进展[J]. 中华肝脏外科手术学电子杂志, 2023, 12(04): 361-366.
阅读次数
全文


摘要